In a report released on February 11, Brian Abrahams from RBC Capital maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research ...
In a report released yesterday, Brad Heffern from RBC Capital maintained a Buy rating on Independence Realty (IRT – Research Report), with a ...
Fractional trading of shares and exchange-traded funds is one of those breakthroughs in DIY investing that come along every ...
RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...
However, the threat of a severe economic shock is also present. “Any major economic disruption, such as widespread job losses resulting from trade tensions, could dampen housing demand and weaken ...
The strategic pivot to investment banking in the U.S., which coincided with pulling out of an unsuccessful and capital-intensive foray into the ultra-competitive and regulation-heavy retail banking ...
pence - 'overweight' RBC raises Schroders to 'outperform' (sector perform) - price target 395 (330) pence Jefferies raises Crest Nicholson price target to 216 (208) pence - 'buy' RBC cuts Crest ...
BP CEO Murray Auchincloss pledged on Tuesday to fundamentally reset the company's strategy as it reported a 35% fall in ...
pence - 'buy' RBC raises Pennon to 'outperform' (sector perform) - price target 600 (675) pence UBS cuts Pennon price target to 630 (666) pence - 'buy' Goldman Sachs cuts Pennon price target to ...